Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  8/20/2012
Forest Investigative Site 010
mi
from
Costa Mesa, CA
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 8/20/2012
Forest Investigative Site 010
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  8/20/2012
Forest Investigative site 005
mi
from
Pembroke Pines, FL
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 8/20/2012
Forest Investigative site 005
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  8/20/2012
Forest Investigative site 004
mi
from
Tampa, FL
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 8/20/2012
Forest Investigative site 004
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  8/20/2012
Forest Investigative Site
mi
from
Atlanta, GA
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 8/20/2012
Forest Investigative Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  8/20/2012
Forest Investigative Site 001
mi
from
Towson, MD
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 8/20/2012
Forest Investigative Site 001
mi
from
Towson, MD
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  8/20/2012
Forest Investigative Site
mi
from
Cleveland, OH
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 8/20/2012
Forest Investigative Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  8/20/2012
Forest Investigative site 011
mi
from
Broomall, PA
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 8/20/2012
Forest Investigative site 011
mi
from
Broomall, PA
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  8/20/2012
Forest Investigative Site
mi
from
Lincoln, RI
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 8/20/2012
Forest Investigative Site
mi
from
Lincoln, RI
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  8/20/2012
Forest Investigative Site
mi
from
Memphis, TN
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 8/20/2012
Forest Investigative Site
mi
from
Memphis, TN
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  8/20/2012
Forest Investigative Site
mi
from
Houston, TX
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 8/20/2012
Forest Investigative Site
mi
from
Houston, TX
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  8/20/2012
Forest Investigative Site
mi
from
Bellevue, WA
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 8/20/2012
Forest Investigative Site
mi
from
Bellevue, WA
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  8/20/2012
Forest Investigative Site #027
mi
from
Seattle, WA
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 8/20/2012
Forest Investigative Site #027
mi
from
Seattle, WA
Click here to add this to my saved trials
Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction
A Feasibility Study of Donepezil in Female Breast Cancer Survivors With Self-Reported Cognitive Dysfunction Following Chemotherapy
Status: Enrolling
Updated:  8/24/2012
Wake Forest Cancer Center CCOP Research Base
mi
from
Winston Salem, NC
Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction
A Feasibility Study of Donepezil in Female Breast Cancer Survivors With Self-Reported Cognitive Dysfunction Following Chemotherapy
Status: Enrolling
Updated: 8/24/2012
Wake Forest Cancer Center CCOP Research Base
mi
from
Winston Salem, NC
Click here to add this to my saved trials
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated:  8/30/2012
GSK Investigational Site
mi
from
Cerritos, CA
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated: 8/30/2012
GSK Investigational Site
mi
from
Cerritos, CA
Click here to add this to my saved trials
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated:  8/30/2012
GSK Investigational Site
mi
from
San Diego, CA
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated: 8/30/2012
GSK Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated:  8/30/2012
GSK Investigational Site
mi
from
Torrance, CA
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated: 8/30/2012
GSK Investigational Site
mi
from
Torrance, CA
Click here to add this to my saved trials
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated:  8/30/2012
GSK Investigational Site
mi
from
Jacksonville, FL
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated: 8/30/2012
GSK Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated:  8/30/2012
GSK Investigational Site
mi
from
Miami, FL
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated: 8/30/2012
GSK Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated:  8/30/2012
GSK Investigational Site
mi
from
Atlanta, GA
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated: 8/30/2012
GSK Investigational Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated:  8/30/2012
GSK Investigational Site
mi
from
Marietta, GA
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated: 8/30/2012
GSK Investigational Site
mi
from
Marietta, GA
Click here to add this to my saved trials
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated:  8/30/2012
GSK Investigational Site
mi
from
Chicago, IL
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated: 8/30/2012
GSK Investigational Site
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated:  8/30/2012
GSK Investigational Site
mi
from
Skokie, IL
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated: 8/30/2012
GSK Investigational Site
mi
from
Skokie, IL
Click here to add this to my saved trials
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated:  8/30/2012
GSK Investigational Site
mi
from
Shreveport, LA
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated: 8/30/2012
GSK Investigational Site
mi
from
Shreveport, LA
Click here to add this to my saved trials
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated:  8/30/2012
GSK Investigational Site
mi
from
Rockville, MD
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated: 8/30/2012
GSK Investigational Site
mi
from
Rockville, MD
Click here to add this to my saved trials
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated:  8/30/2012
GSK Investigational Site
mi
from
Albuquerque, NM
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated: 8/30/2012
GSK Investigational Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated:  8/30/2012
GSK Investigational Site
mi
from
Raleigh, NC
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated: 8/30/2012
GSK Investigational Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated:  8/30/2012
GSK Investigational Site
mi
from
Cincinnati, OH
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated: 8/30/2012
GSK Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated:  8/30/2012
GSK Investigational Site
mi
from
Philadelphia, PA
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated: 8/30/2012
GSK Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated:  8/30/2012
GSK Investigational Site
mi
from
Memphis, TN
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated: 8/30/2012
GSK Investigational Site
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated:  8/30/2012
GSK Investigational Site
mi
from
Brown Deer, WI
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated: 8/30/2012
GSK Investigational Site
mi
from
Brown Deer, WI
Click here to add this to my saved trials
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated:  8/30/2012
GSK Investigational Site
mi
from
Madison, WI
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder
Status: Enrolling
Updated: 8/30/2012
GSK Investigational Site
mi
from
Madison, WI
Click here to add this to my saved trials
Testing the Effectiveness of Adolescent Depression Prevention Programs (The OregonBlues Study)
Effectiveness Trial of an Adolescent Depression Prevention Program
Status: Enrolling
Updated:  9/3/2012
Oregon Research Institute
mi
from
Eugene, OR
Testing the Effectiveness of Adolescent Depression Prevention Programs (The OregonBlues Study)
Effectiveness Trial of an Adolescent Depression Prevention Program
Status: Enrolling
Updated: 9/3/2012
Oregon Research Institute
mi
from
Eugene, OR
Click here to add this to my saved trials
Cognitive Behavioral Therapy Delivered Over the Internet for Women With Postpartum Depression
Web-Based Cognitive Behavioral Intervention for Women With Postpartum Depression
Status: Enrolling
Updated:  9/3/2012
University of Iowa
mi
from
Iowa City, IA
Cognitive Behavioral Therapy Delivered Over the Internet for Women With Postpartum Depression
Web-Based Cognitive Behavioral Intervention for Women With Postpartum Depression
Status: Enrolling
Updated: 9/3/2012
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Cognitive Behavioral Therapy Delivered Over the Internet for Women With Postpartum Depression
Web-Based Cognitive Behavioral Intervention for Women With Postpartum Depression
Status: Enrolling
Updated:  9/3/2012
Oregon Research Institute
mi
from
Eugene, OR
Cognitive Behavioral Therapy Delivered Over the Internet for Women With Postpartum Depression
Web-Based Cognitive Behavioral Intervention for Women With Postpartum Depression
Status: Enrolling
Updated: 9/3/2012
Oregon Research Institute
mi
from
Eugene, OR
Click here to add this to my saved trials
Designing and Testing a Family Therapy for Adolescent Depression
Family Therapy for Adolescent Depression: Deployment Focused Development, Phase 1
Status: Enrolling
Updated:  9/5/2012
Oregon Research Institute
mi
from
Eugene, OR
Designing and Testing a Family Therapy for Adolescent Depression
Family Therapy for Adolescent Depression: Deployment Focused Development, Phase 1
Status: Enrolling
Updated: 9/5/2012
Oregon Research Institute
mi
from
Eugene, OR
Click here to add this to my saved trials
Designing and Testing a Family Therapy for Adolescent Depression
Family Therapy for Adolescent Depression: Deployment Focused Development, Phase 1
Status: Enrolling
Updated:  9/5/2012
Options Counseling
mi
from
Eugene, OR
Designing and Testing a Family Therapy for Adolescent Depression
Family Therapy for Adolescent Depression: Deployment Focused Development, Phase 1
Status: Enrolling
Updated: 9/5/2012
Options Counseling
mi
from
Eugene, OR
Click here to add this to my saved trials
Single IV Dose of GLYX-13 in Patients With Treatment-Resistant Depression
Randomized, Double Blind, Placebo Controlled, Single IV Dose Parallel Efficacy and Safety Study of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants During the Current Episode of Major Depressive Disorder
Status: Enrolling
Updated:  9/10/2012
Mulitple
mi
from
Evanston, IL
Single IV Dose of GLYX-13 in Patients With Treatment-Resistant Depression
Randomized, Double Blind, Placebo Controlled, Single IV Dose Parallel Efficacy and Safety Study of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants During the Current Episode of Major Depressive Disorder
Status: Enrolling
Updated: 9/10/2012
Mulitple
mi
from
Evanston, IL
Click here to add this to my saved trials
Helping Others Toward Positive Emotions in People With Heart Failure
Testing a Brief Cognitive Therapy Intervention for Depressive Symptoms in Patients With Heart Failure
Status: Enrolling
Updated:  9/12/2012
University of Kentucky Chandler Medical Center
mi
from
Lexington, KY
Helping Others Toward Positive Emotions in People With Heart Failure
Testing a Brief Cognitive Therapy Intervention for Depressive Symptoms in Patients With Heart Failure
Status: Enrolling
Updated: 9/12/2012
University of Kentucky Chandler Medical Center
mi
from
Lexington, KY
Click here to add this to my saved trials
Depression Outcomes Study of Exercise
Adapting Exercise Treatment for Depression to Adolescents: A Pilot Study
Status: Enrolling
Updated:  9/14/2012
Klein Buendel, Inc
mi
from
Golden, CO
Depression Outcomes Study of Exercise
Adapting Exercise Treatment for Depression to Adolescents: A Pilot Study
Status: Enrolling
Updated: 9/14/2012
Klein Buendel, Inc
mi
from
Golden, CO
Click here to add this to my saved trials
Stimulant Enhancement of Well-Being Therapy for Depression
Stimulant Enhancement of Well-Being Therapy for Depression
Status: Enrolling
Updated:  9/17/2012
Depression Clinical and Research Program
mi
from
Boston, MA
Stimulant Enhancement of Well-Being Therapy for Depression
Stimulant Enhancement of Well-Being Therapy for Depression
Status: Enrolling
Updated: 9/17/2012
Depression Clinical and Research Program
mi
from
Boston, MA
Click here to add this to my saved trials
Mindfulness-based Stress Reduction and Cognitive Function in Stress and Aging
Mindfulness-based Stress Reduction and Cognitive Function in Stress and Aging
Status: Enrolling
Updated:  9/25/2012
University of California at San Diego
mi
from
San Diego, CA
Mindfulness-based Stress Reduction and Cognitive Function in Stress and Aging
Mindfulness-based Stress Reduction and Cognitive Function in Stress and Aging
Status: Enrolling
Updated: 9/25/2012
University of California at San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Mindfulness-based Stress Reduction and Cognitive Function in Stress and Aging
Mindfulness-based Stress Reduction and Cognitive Function in Stress and Aging
Status: Enrolling
Updated:  9/25/2012
Washington University
mi
from
St Louis, MO
Mindfulness-based Stress Reduction and Cognitive Function in Stress and Aging
Mindfulness-based Stress Reduction and Cognitive Function in Stress and Aging
Status: Enrolling
Updated: 9/25/2012
Washington University
mi
from
St Louis, MO
Click here to add this to my saved trials
Eszopiclone Co-Administered With Escitalopram for Insomnia in Elderly Adults With Major Depressive Disorder
Eszopiclone Co-Administered With Escitalopram for Insomnia in Elderly Adults With Major Depressive Disorder
Status: Enrolling
Updated:  10/2/2012
Lehigh Center for Clinical Research
mi
from
Allentown, PA
Eszopiclone Co-Administered With Escitalopram for Insomnia in Elderly Adults With Major Depressive Disorder
Eszopiclone Co-Administered With Escitalopram for Insomnia in Elderly Adults With Major Depressive Disorder
Status: Enrolling
Updated: 10/2/2012
Lehigh Center for Clinical Research
mi
from
Allentown, PA
Click here to add this to my saved trials
Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression
Determining Effectiveness of Multi-Coil rTMS for Patients With Major Depressive Disorder: A Pilot Study
Status: Enrolling
Updated:  10/4/2012
Emory University
mi
from
Atlanta, GA
Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression
Determining Effectiveness of Multi-Coil rTMS for Patients With Major Depressive Disorder: A Pilot Study
Status: Enrolling
Updated: 10/4/2012
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression
Determining Effectiveness of Multi-Coil rTMS for Patients With Major Depressive Disorder: A Pilot Study
Status: Enrolling
Updated:  10/4/2012
Rush Medical College
mi
from
Chicago, IL
Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression
Determining Effectiveness of Multi-Coil rTMS for Patients With Major Depressive Disorder: A Pilot Study
Status: Enrolling
Updated: 10/4/2012
Rush Medical College
mi
from
Chicago, IL
Click here to add this to my saved trials
Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression
Determining Effectiveness of Multi-Coil rTMS for Patients With Major Depressive Disorder: A Pilot Study
Status: Enrolling
Updated:  10/4/2012
Medical University of South Carolina
mi
from
Charleston, SC
Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression
Determining Effectiveness of Multi-Coil rTMS for Patients With Major Depressive Disorder: A Pilot Study
Status: Enrolling
Updated: 10/4/2012
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Cognitive-behavioral Therapy vs. Light Therapy for Preventing SAD Recurrence
Cognitive-behavioral Therapy vs. Light Therapy for Preventing Seasonal Affective Disorder Recurrence
Status: Enrolling
Updated:  10/22/2012
University of Vermont, Psychology Department
mi
from
Burlington, VT
Cognitive-behavioral Therapy vs. Light Therapy for Preventing SAD Recurrence
Cognitive-behavioral Therapy vs. Light Therapy for Preventing Seasonal Affective Disorder Recurrence
Status: Enrolling
Updated: 10/22/2012
University of Vermont, Psychology Department
mi
from
Burlington, VT
Click here to add this to my saved trials
Research on Outpatient Adolescent Treatment for Comorbid Substance Use and Internalizing Disorders
Stage II Research on Outpatient Treatment for Adolescents With Comorbidity
Status: Enrolling
Updated:  10/31/2012
Medical University of South Carolina, Department of Psychiatry & Behavioral Sciences, Family Services Research Center
mi
from
Charleston, SC
Research on Outpatient Adolescent Treatment for Comorbid Substance Use and Internalizing Disorders
Stage II Research on Outpatient Treatment for Adolescents With Comorbidity
Status: Enrolling
Updated: 10/31/2012
Medical University of South Carolina, Department of Psychiatry & Behavioral Sciences, Family Services Research Center
mi
from
Charleston, SC
Click here to add this to my saved trials
Yoga for Persons With Severe Visual Impairment
Development of a Yoga Intervention for Symptoms Related to Severe Visual Impairment
Status: Enrolling
Updated:  10/31/2012
Lions Vision and Research Rehabilitation
mi
from
Baltimore, MD
Yoga for Persons With Severe Visual Impairment
Development of a Yoga Intervention for Symptoms Related to Severe Visual Impairment
Status: Enrolling
Updated: 10/31/2012
Lions Vision and Research Rehabilitation
mi
from
Baltimore, MD
Click here to add this to my saved trials
Cognitive Deficits in Major Depressive Disorder and Bipolar Disorder, Depressed Type: Prevalence and Improvement With Treatment of Depressive Symptoms
Cognitive Deficits in Major Depressive Disorder and Bipolar Disorder Depressed Type: Prevalence and Symptoms With Treating of Depressive Symptoms
Status: Enrolling
Updated:  11/2/2012
Massachusetts General Hospital
mi
from
Boston, MA
Cognitive Deficits in Major Depressive Disorder and Bipolar Disorder, Depressed Type: Prevalence and Improvement With Treatment of Depressive Symptoms
Cognitive Deficits in Major Depressive Disorder and Bipolar Disorder Depressed Type: Prevalence and Symptoms With Treating of Depressive Symptoms
Status: Enrolling
Updated: 11/2/2012
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials